Search research articles
Contact Us
Filters
Showing results (131-140 of 322) with videos related to
Page
of 33
Sort By:
Drugs
|
August 27, 2004
Inhaled salmeterol/fluticasone propionate: a review of its use in chronic obstructive pulmonary disease
Caroline Fenton, Gillian M Keating
Drugs
|
May 2, 2009
Fesoterodine
Kate McKeage, Gillian M Keating
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
July 25, 2009
Spotlight on sapropterin in primary hyperphenylalaninemia
Mark Sanford, Gillian M Keating
Drugs
|
March 6, 2007
Agalsidase Beta: a review of its use in the management of Fabry disease
Gillian M Keating, Dene Simpson
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
July 14, 2007
Spotlight on agalsidase beta in Fabry disease
Gillian M Keating, Dene Simpson
Drugs
|
November 20, 2008
Enteric-coated mycophenolate sodium: a review of its use in the prevention of renal transplant rejection
Mark Sanford, Gillian M Keating
Drugs
|
April 6, 2013
Lixisenatide: first global approval
Shelley Elkinson, Gillian M Keating
American Journal of Clinical Dermatology
|
April 24, 2008
Clindamycin/benzoyl peroxide gel (BenzaClin): a review of its use in the management of acne
Kate McKeage, Gillian M Keating
Drugs
|
January 21, 2014
Sofosbuvir: first global approval
Gillian M Keating, Asha Vaidya
Drugs
|
August 7, 2010
Glatiramer acetate: a review of its use in relapsing-remitting multiple sclerosis and in delaying the onset of clinically definite multiple sclerosis
Natalie J Carter, Gillian M Keating
Page
of 33
Search research articles
Search
Showing results (131-140 of 322) with videos related to
Sort By:
Page
of 33
Drugs
|
August 27, 2004
Inhaled salmeterol/fluticasone propionate: a review of its use in chronic obstructive pulmonary disease
Caroline Fenton, Gillian M Keating
Drugs
|
May 2, 2009
Fesoterodine
Kate McKeage, Gillian M Keating
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
July 25, 2009
Spotlight on sapropterin in primary hyperphenylalaninemia
Mark Sanford, Gillian M Keating
Drugs
|
March 6, 2007
Agalsidase Beta: a review of its use in the management of Fabry disease
Gillian M Keating, Dene Simpson
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
July 14, 2007
Spotlight on agalsidase beta in Fabry disease
Gillian M Keating, Dene Simpson
Drugs
|
November 20, 2008
Enteric-coated mycophenolate sodium: a review of its use in the prevention of renal transplant rejection
Mark Sanford, Gillian M Keating
Drugs
|
April 6, 2013
Lixisenatide: first global approval
Shelley Elkinson, Gillian M Keating
American Journal of Clinical Dermatology
|
April 24, 2008
Clindamycin/benzoyl peroxide gel (BenzaClin): a review of its use in the management of acne
Kate McKeage, Gillian M Keating
Drugs
|
January 21, 2014
Sofosbuvir: first global approval
Gillian M Keating, Asha Vaidya
Drugs
|
August 7, 2010
Glatiramer acetate: a review of its use in relapsing-remitting multiple sclerosis and in delaying the onset of clinically definite multiple sclerosis
Natalie J Carter, Gillian M Keating
Page
of 33